TABLE 1.
Expression | ||||
---|---|---|---|---|
Total (n = 408) | High (n = 205) | Low (n = 203) | p_value | |
Gender | ||||
female | 192 (47.1%) | 99 (48.3%) | 93 (45.8%) | 0.687 |
male | 216 (52.9%) | 106 (51.7%) | 110 (54.2%) | |
Age (years) | 0.138 | |||
≥ 60 | 290 (71.1%) | 153 (74.6%) | 137 (67.5%) | |
<60 | 118 (28.9%) | 52 (25.4%) | 66 (32.5%) | |
Pathologic stage | 0.592 | |||
stage_Ⅰ | 67 (16.4%) | 32 (15.6%) | 35 (17.2%) | |
stage_Ⅱ | 152 (37.3%) | 74 (36.1%) | 78 (38.4%) | |
stage_Ⅲ | 122 (29.9%) | 61 (29.8%) | 61 (30.0%) | |
stage_Ⅳ | 53 (13.0%) | 32 (15.6%) | 21 (10.3%) | |
unknown | 14 (3.4%) | 6 (2.9%) | 8 (3.8%) | |
T stage | ||||
T1 | 9 (2.2%) | 6 (2.9%) | 3 (1.5%) | 0.568 |
T2 | 71 (17.4%) | 32 (15.6%) | 39 (19.2%) | |
T3 | 290 (71.1%) | 146 (71.2%) | 144 (70.9%) | |
T4 | 37 (9.1%) | 20 (9.8%) | 17 (8.4%) | |
unknown | 1 (0.2%) | 1 (0.5%) | 0 (0%) | |
M stage | 0.174 | |||
M0 | 302 (74.0%) | 148 (72.2%) | 154 (75.9%) | |
M1 | 52 (12.7%) | 32 (15.6%) | 20 (9.9%) | |
MX | 45 (11.0%) | 19 (9.3%) | 26 (12.8%) | |
unknown | 9 (2.2%) | 6 (2.9%) | 3 (1.5%) | |
N stage | 0.285 | |||
N0 | 231 (56.6%) | 112 (54.6%) | 119 (58.6%) | |
N1 | 92 (22.5%) | 42 (20.5%) | 50 (24.6%) | |
N2 | 82 (20.1%) | 49 (23.9%) | 33 (16.3%) | |
NX | 2 (0.5%) | 1 (0.5%) | 1 (0.5%) | |
unknown | 1 (0.2%) | 1 (0.5%) | 0 (0%) |